JASON ROH, MD
Osteopathic Medicine at Pilgrim Rd, Boston, MA
License number
Massachusetts 247055
Category
Osteopathic Medicine
Type
Internal Medicine
License number
Massachusetts 247055
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
185 Pilgrim Rd, Boston, MA 02215
Phone
(617) 632-7828
(617) 632-7536 (Fax)
(203) 233-8788
(617) 632-7536 (Fax)
(203) 233-8788
Personal information
See more information about JASON ROH at radaris.comName
Address
Phone
79 Gainsborough St UNIT 408, Boston, MA 02115
79 Gainsborough St, Boston, MA 02115
Professional information
Dr. Jason D Roh, Boston MA - MD (Doctor of Medicine)
Specialties:
Cardiology
Age:
45
Address:
HEALTH CARE ASSOCIATES
330 Brookline Ave, Boston 02215
(617) 667-7000 (Phone), (617) 667-8000 (Fax)
Beth Israel Dcnss Med Ctr Crdlg
185 Pilgrim Rd SUITE 4, Boston 02215
(617) 632-7828 (Phone)
330 Brookline Ave, Boston 02215
(617) 667-7000 (Phone), (617) 667-8000 (Fax)
Beth Israel Dcnss Med Ctr Crdlg
185 Pilgrim Rd SUITE 4, Boston 02215
(617) 632-7828 (Phone)
Languages:
English
Education:
Medical School
Yale University
Graduated: 2006
Yale University
Graduated: 2006
Compositions And Methods For Promoting Patency Of Vascular Grafts
US Patent:
2010030, Dec 2, 2010
Filed:
Jan 8, 2009
Appl. No.:
12/811676
Inventors:
Christopher Breuer - Bethany CT, US
Themis Kyriakides - Branford CT, US
Jason Roh - Boston MA, US
Themis Kyriakides - Branford CT, US
Jason Roh - Boston MA, US
Assignee:
Yale University - New Haven CT
International Classification:
A61F 2/90, A61K 38/20, A61K 38/18, A61K 38/19, A61P 43/00
US Classification:
424426, 424 852, 514 76, 424 851
Abstract:
Methods for increasing the patency of biodegradable, synthetic vascular grafts are provided. The methods include administering one or more cytokines and/or chemokines that promote outward tissue remodeling of the vascular grafts and vascular neotissue formation. The disclosed methods do not require cell seeding of the vascular grafts, thus avoiding many problems associated with cell seeding. Biodegradable, polymeric vascular grafts which provide controlled release of cytokines and/or chemokines at the site of vascular graft implantation are also provided.